Join Dr. Abramoff has he joins a minisymposia at ARVO 2025 along side Malvina Eydelman, Noelle Whitestone, Lama Al Aswad, Amitha Domalpally, and Aaron Lee.
Description of talk: There has been an explosion of AI research in ophthalmology, yet only a handful of these innovations have achieved FDA certification and are actively used in patient care. This session aims to address the critical question: how can we, as the ARVO community, move beyond the current barriers to bring more AI tools into real-world applications? Attendees will gain insights from experts on navigating the FDA’s Total Product Lifecycle (TPLC), and international regulation and certification processes. Challenges to AI implementation in glaucoma and retinal diseases will be discussed, along with strategies for achieving regulatory compliance and ensuring ethical AI use.